CDC, PerkinElmer Readying Molecular SMA Tests as Stakeholders Push for Nationwide Newborn Screening
Parents’ Experiences 12 Years after Newborn Screening for Genetic Susceptibility to Type 1 Diabetes and Their Attitudes to Whole-Genome Sequencing in Newborns
Development of a Tiered and Binned Genetic Counseling Model for Informed Consent in the Era of Multiplex Testing for Cancer Susceptibility
The FDA and 23andMe: Overreaching and overreacting?
Prenatal Identification of Increased Risk for Schizophrenia
Genetic Information Not Always Benign
Does Genetic Testing Pose Psychosocial Risks?
Columbia University to Explore Impact of Genetic Information about Autism on Families, Individuals
Neuropsychiatric Conditions and Genetic Variation – Is Autism Really a Disease?
Do Genetic Findings Impact Perceptions of Responsibility? A Public Virtual Symposium
Should We Be Conducting Genomic Screening in US Adults to Assess Risk of Future Disease?
Precision Cancer Medicine: What About the Germline?
Issue Briefs & Commentaries »
The FDA and 23andMe: Overreaching and overreacting?
Prenatal Identification of Increased Risk for Schizophrenia
Genetic Information Not Always Benign
Press Releases »
Does Genetic Testing Pose Psychosocial Risks?
Columbia University to Explore Impact of Genetic Information about Autism on Families, Individuals
Events »
Neuropsychiatric Conditions and Genetic Variation – Is Autism Really a Disease?
Do Genetic Findings Impact Perceptions of Responsibility? A Public Virtual Symposium
Should We Be Conducting Genomic Screening in US Adults to Assess Risk of Future Disease?
Precision Cancer Medicine: What About the Germline?
Click here to subscribe to our newsletter!
This center is a Center for Excellence in ELSI Research funded by a grant from the National Institutes of Health #RM1HG007257-06